Patient Buzz Series | Estrogen Creams for the Face?
A recent myth-busting column in The Washington Post addressed if estrogen creams can prevent skin aging when applied to the face. The column noted that research is lacking on the facial use of estrogen creams. However, research does show that estrogen creams can improve skin when applied topically in menopausal women, and some dermatologists do prescribe estrogen creams off-label for facial use.
…
A recent myth-busting column in The Washington Post addressed if estrogen creams can prevent skin aging when applied to the face. The column noted that research is lacking on the facial use of estrogen creams. However, research does show that estrogen creams can improve skin when applied topically in menopausal women, and some dermatologists do prescribe estrogen creams off-label for facial use.
… Continue reading "Patient Buzz Series | Estrogen Creams for the Face?"
Ketoconazole is an imidazole antifungal that was initially FDA-approved in an oral formulation for the treatment of systemic fungal infections. While oral ketoconazole has largely fallen out of use due to safety concerns, including hepatotoxicity, endocrine dysregulation, and drug interactions, topical ketoconazole has proven to be a safe and effective treatment for superficial fungal infections. … 
Are AI chatbots a wave of the future in dermatology? An article in the November Journal of Drugs in Dermatology assessed dermatologists’ attitudes and beliefs toward artificial intelligence chatbots. Chatbot usage has grown in a variety of areas of society in recent years, and ChatGPT’s popularity shows there’s demand. So to what extent do dermatologists think AI chatbots will play a role in … 
Patients with the above condition should be evaluated for what immunodeficiency?
A. C5-9
B. IgM
C. C3
D. B2-integrin
E. Immunoglobulin
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
… 
At the Skin of Color Update 2024, we had the honor to learn from Dr. Rebecca Vasquez, Associate Professor at UT Southwestern Medical Center, regarding the evolving field of vitiligo management. Vitiligo affects between 0.5% to 2% of the global population, with no racial or gender preference, yet it carries a significant psychological burden for affected individuals.1 Dr. Vasquez emphasized that vi …